Results 201 to 210 of about 69,250 (228)

Myeloproliferative Neoplasm (MPN)

2020
MPNs comprise various groups of clonal hematopoietic stem cell disorders. The WHO classification 2017 subdivides MPNs into BCR-ABL1-positive chronic myeloid leukaemia (CML) and BCR-ABL1-negative or Philadelphia (Ph) chromosome negative MPNs.
Christine Beham-Schmid, Annette Schmitt-Graeff   +1 more
openaire   +1 more source

MPN-associated myelofibrosis (MPN-MF)

Leukemia Research, 2011
R A, Mesa, A, Green, G, Barosi, S, Verstovsek, J, Vardiman, R P, Gale   +5 more
openaire   +2 more sources

Myeloproliferative neoplasms (MPNs)

Blood Reviews, 2020
openaire   +2 more sources

Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives

Cells, 2021
Julian Baumeister, Nicolas Chatain, Alexandros Marios Sofías   +2 more
exaly  

MPN and transplantation

Leukemia Research, 2016
openaire   +2 more sources

Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry

Cancers, 2021
Judith Gecht, Kim Kricheldorf, Martin Grieshammer   +2 more
exaly  

Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN

Cytometry Part B - Clinical Cytometry, 2021
Stefan G C Mestrum, Frans C S Ramaekers, Math P G Leers   +2 more
exaly  

Diagnostics of MPNs – to be or not to be?

Leukemia Research, 2016
openaire   +1 more source

Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

Journal of Hematology and Oncology, 2016
U Platzbecker, E Jost, Steffen Koschmieder   +2 more
exaly  

MPN-531 Direct and Indirect Costs For Patients With Myeloproliferative Neoplasms (MPNs)

Clinical Lymphoma Myeloma and Leukemia, 2023
Jingbo Yu, Michelle Jerry, James Nelson, Taylor Marlin, Evan Braunstein, Nicole Princic   +5 more
openaire   +1 more source